¿Emergencia médica?¿Emergencia? Llame al 911. Salas de emergencias más cercanasEmergencias cercanas

Empresa farmacéutica (etiquetadora ante la FDA)

Noven Therapeutics, LLC

Código de etiquetadora NDC: 68968

¿Qué es una etiquetadora?

La empresa cuyo nombre aparece en el envase y en el directorio de códigos nacionales de medicamentos (NDC) de la FDA. Puede fabricar el medicamento o vender uno fabricado por otra empresa. La primera parte de cada código NDC identifica a la etiquetadora.

Solo datos oficiales de la FDA

Los productos, aprobaciones y retiros vienen de la FDA (directorio NDC, Drugs@FDA, informes de retiros). Los retiros se vinculan a esta empresa por el código NDC del producto retirado.

Si tiene preguntas sobre su medicamento, hable con su médico o farmacéutico. En una emergencia, llame al 911.

De un vistazo

23Productos (NDC)

Medicamentos con receta

Solicitudes de la FDA de estos productos

  • NDA: Solicitud de nuevo medicamento (NDA): así se aprueba un medicamento nuevo, normalmente de marca.
AprobadaSolicitudMedicamentoPatrocinador
22 de marzo de 2022NDA215401 Dextroamphetamine
XELSTRYM
Noven Pharms Inc
11 de octubre de 2019NDA212268 Asenapine
SECUADO
Hisamitsu
29 de octubre de 2012NDA203752 Estradiol
MINIVELLE
Noven
6 de abril de 2006NDA021514 Methylphenidate
DAYTRANA
Noven Pharms Inc
7 de agosto de 1998NDA020870 Estradiol and norethindrone acetate
COMBIPATCH
Noven Pharms Inc

El patrocinador es la empresa titular de la solicitud ante la FDA; puede ser distinta de la etiquetadora.

Cronología de retiros

2024

  1. 31 de octubre de 2024 · Clase II · En curso · D-0055-2025 · Dextroamphetamine

    Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).

    Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN

2023

  1. 10 de marzo de 2023 · Clase II · En curso · D-0471-2023 · Methylphenidate

    Defective Delivery System: Out of specification for shear.

    Daytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5553-3

  2. 10 de marzo de 2023 · Clase II · En curso · D-0473-2023 · Methylphenidate

    Defective Delivery System: Out of specification for shear.

    Daytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5555-3

  3. 10 de marzo de 2023 · Clase II · En curso · D-0472-2023 · Methylphenidate

    Defective Delivery System: Out of specification for shear.

    Daytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5554-3.

  4. 10 de marzo de 2023 · Clase II · En curso · D-0470-2023 · Methylphenidate

    Defective Delivery System: Out of specification for shear.

    Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5552-3.

2022

  1. 16 de noviembre de 2022 · Clase II · En curso · D-0071-2023 · Methylphenidate

    Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.

    Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 3

  2. 24 de junio de 2022 · Clase II · En curso · D-1169-2022 · Methylphenidate

    Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.

    Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 331

  3. 6 de mayo de 2022 · Clase II · En curso · D-0889-2022 · Methylphenidate

    Defective Delivery System: customer complaints exceeded respective action limits.

    Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 3

2021

  1. 30 de julio de 2021 · Clase II · En curso · D-0724-2021 · Estradiol and norethindrone acetate

    Failed Stability Specifications; out of specification for shear.

    Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, Rx Only a) 2 Systems NDC 68968-0514-2 b) 8 Systems NDC 68968-0514-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami,

  2. 30 de julio de 2021 · Clase II · En curso · D-0725-2021 · Estradiol and norethindrone acetate

    Failed Stability Specifications; out of specification for shear.

    Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day 50/250 Twice Weekly Rx Only a) 2 Systems NDC 68968-0525-2; b) 8 Systems NDC 68968-0525-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami,

Mostrar los 45 retiros anteriores

2021

  1. 20 de mayo de 2021 · Clase II · En curso · D-0393-2021 · Methylphenidate

    Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.

    Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), 30 Patches (NDC 68968-5552-1) per box (NDC 68968-5552-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By No

  2. 20 de mayo de 2021 · Clase II · En curso · D-0394-2021 · Methylphenidate

    Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.

    Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), 30 Patches (NDC 68968-5553-1) per box (NDC 68968-5553-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By No

  3. 16 de abril de 2021 · Clase II · Cerrado por la FDA · D-0337-2021 · Estradiol

    Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

    Estradiol Transdermal System Delivers 0.0375 mg/day, 8 Systems/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-3437-8

  4. 16 de abril de 2021 · Clase II · Cerrado por la FDA · D-0336-2021 · Estradiol

    Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

    Minivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-6675-8

  5. 19 de febrero de 2021 · Clase II · Cerrado por la FDA · D-0296-2021 · Methylphenidate

    Defective Delivery System: Out of specification for mechanical peel.

    Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) Contains: 30 Patches in a foil-sealed polypropylene tray, packed in a paper carton, Rx only, Manufactured for Noven Therapeutics, LLC,

  6. 19 de febrero de 2021 · Clase II · Cerrado por la FDA · D-0295-2021 · Methylphenidate

    Defective Delivery System: Out of specification for mechanical peel.

    Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) Contains: 30 Patches in a foil-sealed polypropylene tray, packed in a paper carton, Rx only, Manufactured for Noven Therapeutics, LLC,

  7. 19 de febrero de 2021 · Clase II · Cerrado por la FDA · D-0294-2021 · Methylphenidate

    Defective Delivery System: Out of specification for mechanical peel.

    Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), Contains: 30 Patches in in a foil-sealed polypropylene tray, packed in a paper carton, Rx only, Manufactured for Noven Therapeutics,

  8. 19 de febrero de 2021 · Clase II · Cerrado por la FDA · D-0293-2021 · Methylphenidate

    Defective Delivery System: Out of specification for mechanical peel.

    Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), Contains: 30 Patches in a foil-sealed polypropylene tray, packed in a paper carton, Rx only, Manufactured for Noven Therapeutics, LL

2020

  1. 31 de marzo de 2020 · Clase II · Cerrado por la FDA · D-1248-2020 · Methylphenidate

    Defective Delivery System: Out of specification for mechanical peel and shear.

    Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC Miami, FL 33186, NDC 68968-5554-3

  2. 31 de marzo de 2020 · Clase II · Cerrado por la FDA · D-1249-2020 · Methylphenidate

    Defective Delivery System: Out of specification for mechanical peel and shear.

    Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC Miami, FL 33186, NDC 68968-5555-3

  3. 31 de marzo de 2020 · Clase II · Cerrado por la FDA · D-1247-2020 · Methylphenidate

    Defective Delivery System: Out of specification for mechanical peel and shear.

    Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC Miami, FL 33186, NDC 68968-5552-3

  4. 2 de marzo de 2020 · Clase II · Cerrado por la FDA · D-1045-2020 · Methylphenidate

    Defective Delivery System: Out of specification for mechanical peel and shear.

    Daytrana (methylphenidate transdermal system) patches, Delivers 30 mg over 9 hours (3.3 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186, NDC 68968-5555-3

  5. 2 de marzo de 2020 · Clase II · Cerrado por la FDA · D-1044-2020 · Methylphenidate

    Defective Delivery System: Out of specification for mechanical peel and shear.

    Daytrana (methylphenidate transdermal system) patches, Delivers 20 mg over 9 hours (2.2 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186, NDC 68968-5554-3

  6. 2 de marzo de 2020 · Clase II · Cerrado por la FDA · D-1042-2020 · Methylphenidate

    Defective Delivery System: Out of specification for mechanical peel and shear.

    Daytrana (methylphenidate transdermal system) patches, Delivers 10 mg over 9 hours (1.1 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186, NDC 68968-5552-3

  7. 2 de marzo de 2020 · Clase II · Cerrado por la FDA · D-1043-2020 · Methylphenidate

    Defective Delivery System: Out of specification for mechanical peel and shear.

    Daytrana (methylphenidate transdermal system) patches, Delivers 15 mg over 9 hours (1.6 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186, NDC 68968-5553-3

2018

  1. 7 de septiembre de 2018 · Clase II · Cerrado por la FDA · D-1207-2018 · Estradiol

    Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

    Minivelle (estradiol transdermal system) Patches Delivers 0.1 mg/day, a) 2 count and b) 8 count boxes, Rx only, , Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florid

  2. 7 de septiembre de 2018 · Clase II · Cerrado por la FDA · D-1210-2018 · Estradiol

    Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

    Minivelle (estradiol transdermal system) Patches, Delivers 0.075 mg/day, 8 count boxes, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 6

  3. 7 de septiembre de 2018 · Clase II · Cerrado por la FDA · D-1208-2018 · Estradiol

    Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

    Minivelle (estradiol transdermal system) Patches, Delivers 0.05 mg/day, a) 2 count and 8 count boxes, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 3

  4. 7 de septiembre de 2018 · Clase II · Cerrado por la FDA · D-1209-2018 · Estradiol

    Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

    Minivelle (estradiol transdermal system) Patches, Delivers 0.025 mg/day, 8 count boxes, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 6

  5. 4 de mayo de 2018 · Clase II · Cerrado por la FDA · D-0862-2018 · Estradiol

    Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

    Minivelle (estradiol transdermal system) 0.1 mg/day, 1 System per pouch (NDC 68968-6610-1), packaged in 8 pouches per box (NDC 68968-6610-8), Rx only, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186; Dist. by:

  6. 4 de mayo de 2018 · Clase II · Cerrado por la FDA · D-0863-2018 · Estradiol

    Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

    Minivelle (estradiol transdermal system) 0.0375 mg/day, 1 System per pouch (NDC 68968-6637-1), packaged in 8 pouches per box (NDC 68968-6637-8), Rx only, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186; Dist.

  7. 9 de abril de 2018 · Clase II · Cerrado por la FDA · D-0627-2018 · Methylphenidate

    Defective Delivery System: Out of specification for adhesive transfer.

    Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches Rx Only NDC 68968-5552-3 Manufactured for Noven Therapeutics, LLC., Miami, FL 33186 by Noven Pharmaceuticals, Inc

2017

  1. 30 de agosto de 2017 · Clase II · Cerrado por la FDA · D-1170-2017 · Methylphenidate

    Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

    Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 3318

  2. 30 de agosto de 2017 · Clase II · Cerrado por la FDA · D-1169-2017 · Methylphenidate

    Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

    Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 3318

  3. 30 de agosto de 2017 · Clase II · Cerrado por la FDA · D-1172-2017 · Methylphenidate

    Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

    Daytrana (methylphenidate transdermal system) Delivers 15 mg over 9 hours (1.6 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 3318

  4. 30 de agosto de 2017 · Clase II · Cerrado por la FDA · D-1171-2017 · Methylphenidate

    Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

    Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 3318

  5. 27 de abril de 2017 · Clase III · Cerrado por la FDA · D-0923-2017 · Estradiol

    Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.

    Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186. NDC: 68968-6610-8

2016

  1. 22 de agosto de 2016 · Clase II · Cerrado por la FDA · D-0430-2017 · Methylphenidate

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.

    Daytrana (methylphenidate transdermal system) Transdermal Patch, 30 mg over 9 hours (3.3 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceu

  2. 22 de agosto de 2016 · Clase II · Cerrado por la FDA · D-0429-2017 · Methylphenidate

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.

    Daytrana (methylphenidate transdermal system) Transdermal Patch, 20 mg over 9 hours (2.2 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceu

  3. 22 de agosto de 2016 · Clase II · Cerrado por la FDA · D-0428-2017 · Methylphenidate

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.

    Daytrana (methylphenidate transdermal system) Transdermal Patch, 10 mg over 9 hours (1.1mg/hr), packaged in- 30 count per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals,

2015

  1. 21 de diciembre de 2015 · Clase II · Cerrado por la FDA · D-1439-2016 · Methylphenidate

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

    Daytrana (methylphenidate transdermal system) Transdermal Patch, 20 mg over 9 hours (2.2 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceu

  2. 21 de diciembre de 2015 · Clase II · Cerrado por la FDA · D-1438-2016 · Methylphenidate

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

    Daytrana (methylphenidate transdermal system) Transdermal Patch, 15 mg over 9 hours (1.6 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceu

  3. 21 de diciembre de 2015 · Clase II · Cerrado por la FDA · D-1440-2016 · Methylphenidate

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

    Daytrana (methylphenidate transdermal system) Transdermal Patch, 30 mg over 9 hours (3.3 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceu

  4. 27 de julio de 2015 · Clase II · Cerrado por la FDA · D-0008-2016 · Methylphenidate

    Defective Delivery System: Out of specification for z-statistic related to mechanical peel force.

    Daytrana (methylphenidate transdermal system), 30 mg over 9 Hour Patches (3.3 mg/hr), 30 Ct Carton, Rx Only, Manufactured for: Noven Therapies, LLC., Miami, FL 33186, by: Noven Pharmaceuticals, Inc., Miami, FL 33186. NDC

  5. 25 de febrero de 2015 · Clase II · Cerrado por la FDA · D-0485-2015 · Estradiol

    Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.

    Minivelle (estradiol transdermal system) 0.05 mg/day, 8-count box, Rx only, Manufactured by Noven Pharmaceuticals, Inc., Miami, Florida 33186, Distributed by Noven Pharmaceuticals, LLC, Miami, Florida 33186, NDC 68968-66

  6. 12 de enero de 2015 · Clase II · Cerrado por la FDA · D-1086-2015 · Methylphenidate

    Defective Delivery System: One lot exceeded the mechanical peel specification

    Daytrana (methylphenidate transdermal system), Delivers 30 mg over 9 hours (3.3mg/hr), CII, 30 patches per box, Manufactured for Noven Therapeutics LLC, Miami, FL 33186, by Noven Pharmaceuticals Inc., Miami, FL 33186, ND

2014

  1. 15 de julio de 2014 · Clase II · Cerrado por la FDA · D-1608-2014 · Methylphenidate

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

    Daytrana (methylphenidate transdermal system) patch, Delivers 20 mg over 9 hours (2.2mg/hr), 1 patch per pouch , packaged in 30-count patches per box, Rx Only. Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, B

  2. 13 de febrero de 2014 · Clase II · Cerrado por la FDA · D-1172-2014 · Methylphenidate

    Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.

    Daytrana (methylphenidate) transdermal system patch, Delivers 30 mg over 9 hours (3.3mg/hr), 1patch per pouch , packaged in 30-count patches per box, Rx Only.Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By

  3. 13 de febrero de 2014 · Clase II · Cerrado por la FDA · D-1171-2014 · Methylphenidate

    Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.

    Daytrana (methylphenidate) transdermal system patch, Delivers 20 mg over 9 hours (2.2mg/hr), 1 patch per pouch , packaged in 30-count patches per box, Rx Only. Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, B

2013

  1. 31 de enero de 2013 · Clase II · Cerrado por la FDA · D-312-2013 · Methylphenidate

    Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.

    Daytrana (methylphenidate) transdermal system patch, Delivers 10 mg over 9 hours (1.1 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, B

2012

  1. 12 de julio de 2012 · Clase II · Cerrado por la FDA · D-1655-2012 · Methylphenidate

    Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

    Daytrana (methylphenidate) transdermal system patch, Delivers 15 mg over 9 hours (1.6 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, B

  2. 12 de julio de 2012 · Clase II · Cerrado por la FDA · D-1654-2012 · Methylphenidate

    Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

    Daytrana (methylphenidate) transdermal system patch, Delivers 30 mg over 9 hours (3.3 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, B

  3. 12 de julio de 2012 · Clase II · Cerrado por la FDA · D-1653-2012 · Methylphenidate

    Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

    Daytrana (methylphenidate) transdermal system patch, Delivers 20 mg over 9 hours (2.2 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, B

  4. 22 de marzo de 2012 · Clase II · Cerrado por la FDA · D-1413-2012 · Methylphenidate

    Miscalibrated/Defective Delivery System; exceeded the specification for both mechanical peel force (MPF) and/or the z-statistic value

    Daytrana (Methylphenidate) Transdermal System Patch, Delivers 20 mg over 9 hours (2. 2 mg/hr), 1 patch per pouch (NDC 68968-5554-01) packaged in 3-count patches per box (NDC 68968-5554-3) , Rx only, Manufactured for Shir

2011

  1. 5 de julio de 2011 · Clase II · Cerrado por la FDA · D-1372-2012 · Methylphenidate

    Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

    Daytrana (methylphenidate) transdermal system patch, Delivers 20 mg over 9 hours (2.2 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, labeled as a) Manufactured for Shire US Inc., Wayne, PA 1908

¿Qué significan las clases de retiro?

Clase I: El tipo más grave: existe una probabilidad razonable de que usar el producto cause problemas de salud graves o la muerte.
Clase II: Usar el producto puede causar problemas de salud temporales o reversibles con tratamiento, o la probabilidad de problemas graves es remota.
Clase III: No es probable que usar el producto cause problemas de salud (por ejemplo, un problema de etiquetado o de envase).

Fuentes

  1. NDC Directory (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 13 de noviembre de 2026, consultados el 14 de noviembre de 2026
  2. Drugs@FDA (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 13 de noviembre de 2026, consultados el 14 de noviembre de 2026
  3. Drug recall enforcement reports (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 10 de noviembre de 2026, consultados el 14 de noviembre de 2026

Buscador de informes de retiros de la FDA → · Informar un error →